# Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)

> **NCT07119021** · PHASE4 · RECRUITING · sponsor: **Ruijun Ji** · enrollment: 300 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Intravenous thrombolysis + edaravone
- **DRUG:** IV thrombolysis + placebo (control group)

## Key facts

- **NCT ID:** NCT07119021
- **Lead sponsor:** Ruijun Ji
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-07-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07119021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07119021, "Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07119021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*